CHINESE JOURNAL OF MEDICINAL GUIDE >
Exploring the Treatment of Pediatric Guillain-Barré Syndrome from the Perspective of Lung Based on the Theory of Flaccidity Syndrome in the “Huangdi Neijing”
Received date: 2025-11-14
Revised date: 2025-12-14
Accepted date: 2026-04-20
Online published: 2026-06-29
Guillain-Barré syndrome (GBS) is an acute inflammatory autoimmune disease characterized by demyelination of peripheral nerves and nerve roots. In clinical practice, some pediatric GBS patients still experience limb sensory and motor dysfunction after various modern medical treatments, with a tendency for disease recurrence. Most GBS patients have a history of preceding infections. Traditional Chinese medicine often classifies this condition under the category of "flaccidity syndrome". As early as the "Huangdi Neijing" period, a relatively comprehensive explanation of the etiology and pathogenesis of flaccidity syndrome had already been provided, proposing the core pathogenesis of "lung heat scorching" and the treatment principle of "treating flaccidity syndrome by focusing on the Yangming meridian". However, based on summarizing the theories of flaccidity syndrome in the "Huangdi Neijing" and the interpretations by later physicians, this study argues that "focusing on the Yangming" does not imply exclusivity, and merely regulating the spleen and stomach cannot fully address flaccidity syndrome. Considering the etiology of pediatric GBS, the physiological characteristics of "excess of Yang in children", and the functional connection between the lung and spleen, this study has identified "external pathogens invading the lung, stagnating and transforming into heat, heat scorching the lung " as the core pathogenesis of this disease. Phlegm-dampness and blood stasis are significant pathological byproducts. The overall treatment principle should be to address both symptoms and root causes, tonify the deficiency and purge the excess, with a focus on treating the lung. Methods such as dispersing wind, promoting lung function, clearing heat, and unblocking collaterals are employed. The modified formula of Ma Xing Yi Gan decoction combined with Gui Zhi Jia Ge Gen decoction has been clinically validated as effective, offering new insights for clinical diagnosis and treatment.
YU Yue, DING Dandan, LI Min, SHU Ruiying, CHEN Zisu
.
Exploring the Treatment of Pediatric Guillain-Barré
Syndrome from the Perspective of Lung Based on the Theory of Flaccidity
Syndrome in the “Huangdi Neijing”
[1] 中华医学会神经病学分会,中华医学会神经病学分会周围神经病协作组.中国吉兰-巴雷综合征诊治指南2024[J].中华神经科杂志,2024,57(9):936-944.
[2] 周彦慧.吉兰-巴雷综合征发病机制及治疗研究进展[J].中国实用神经疾病杂志,2017,20(7):89-91,131.
[3] Zheng P, Tian DC, Xiu Y, et al. Incidence of Guillain-Barré syndrome (GBS) in China: a national population-based study[J].Lancet Reg Health West Pac, 2021,18:100302.
[4] 张才振,徐靖晖,李晓涵,等.中医治疗格林-巴利综合征的研究进展[J].基层中医药,2022,1(2):68-71.
[5] 李缓,姜海伦,陈昊,等.基于“治痿独取阳明”探讨针刺治疗吉兰-巴雷综合征的思路与方法[J].中医杂志,2024,65(4):362-367.
[6] 赵浩斌,翟双庆.从《黄帝内经》崇阳思想浅谈“治痿独取阳明”[J].中医学报,2022,37(7):1373-1377.
[7] 何婷婷,孙丽霞.“治痿独取阳明”刍议[J].吉林中医药,2008,28(5):322-323.
[8] 董鑫,陈馨雨.《黄帝内经》“治痿独取阳明”理论探讨[J].江西中医药,2025,56(1):18-20.
[9] 董秀娟,刘小斌.与重症肌无力相关的痿证,四肢无力,肌肉萎缩中医学术源流探讨[J].辽宁中医杂志,2012,39(12):2376-2378.
[10] 金子开,孙萌,李凯,等.叶天士辨治痿证思路探析[J].中国中医基础医学杂志,2021,27(10):1554-1556,1594.
[11] 王林,樊永平.温病理论对中枢神经系统炎性脱髓鞘疾病治疗的启发[J].环球中医药,2016,9(10):1204-1206.
[12] 王伟民,吴颖悟.王松龄治疗格林-巴利综合征经验[J].中医杂志,2009,50(8):689-690.
[13] 姬梦丽,苏志伟,赵亚伟,等.苏志伟教授治疗吉兰-巴雷综合征经验[J].现代中西医结合杂志,2020,29(34):3844-3847,3859.
[14] 张松峰.金杰教授治疗吉兰-巴雷综合征经验[J].中医学报,2013,28(12):1816-1817.
[15] 贾晓倩,马云枝,汤银芳.格林巴利综合征的中医分期论治经验[J].中华中医药杂志,2022,37(3):1455-1457.
[16] 侯晓洁,代二庆.小续命汤治疗格林-巴利综合征临床探讨[J].天津中医药,2017,34(8):548-549.
[17] 傅海群,叶晓红,宋成城,等.从外风论治格林-巴利综合征[J].中国中医急症,2020,29(3):542-544.
[18] 邹艺龙,王诗忠.从桂枝加葛根汤浅析《伤寒论》治“项背强几几”的机制[J].湖南中医杂志,2014,30(12):111-112.
[19] 万鑫浩,朱卫丰,杨丽娜,等.经典名方桂枝加葛根汤古今文献考究[J].中华中医药杂志,2023,38(10):4948-4954.
[20] 付屺瞻,韩祖成.格林巴利综合征经方方证初探[J].亚太传统医药,2017,13(21):64-66.
[21] 司徒惠昀,张立山,王婧,等.《伤寒杂病论》利尿解表法辨析[J].江苏中医药,2024,56(9):63-66.
[22] 卓小玉,陈晶,田明,等.麻黄的化学成分与药理作用研究进展[J].中医药信息,2021,38(2):80-83.
[23] 吴国庆,李志刚,杨佳一,等.葛根素的抗炎作用及其对神经系统疾病影响的研究进展[J].中西医结合心脑血管病杂志,2023,21(10):1807-1810.
[24] 李雪,赵婧含,吴文轩,等.桂枝的化学成分和药理作用研究进展[J].中医药学报,2023,51(5):111-114.
/
| 〈 |
|
〉 |